Atlas Trials

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

Clinical trial NCT03917381 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03917381
Sponsor
Genmab
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Solid Tumors
Start date
2019-05-14
Primary completion
2025-04-01
Enrollment
429

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.